Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL697701

COc1cc2nccc(Oc3ccc(NC(=O)c4nn(C)c5ccccc45)cc3F)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 16/20 0.68
AXL P30530 10/20 0.68
MST1R Q04912 2/20 0.62
AURKA O14965 1/20 0.60
JAK2 O60674 1/20 0.60
RPS6KA5 O75582 1/20 0.60
ABL1 P00519 1/20 0.60
INSR P06213 1/20 0.60
LCK P06239 1/20 0.60
RET P07949 1/20 0.60
IGF1R P08069 1/20 0.60
KIT P10721 1/20 0.60
PIM1 P11309 1/20 0.60
FGFR1 P11362 1/20 0.60
SRC P12931 1/20 0.60
PRKACA P17612 1/20 0.60
RPS6KB1 P23443 1/20 0.60
JAK1 P23458 1/20 0.60
MAPK3 P27361 1/20 0.60
AKT1 P31749 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167872 0.96 MET (0.72) METAXLMST1RAURKAJAK2
Trifluoroacetic Acid SCHEMBL168241 0.84 AXL (0.66) METAXLMST1RAURKAJAK2
Trifluoroacetic Acid SCHEMBL696882 0.83 AXL (0.64) METAXLMST1R
Trifluoroacetic Acid SCHEMBL705178 0.83 AXL (0.64) METAXLMST1RAURKAJAK2
Trifluoroacetic Acid SCHEMBL167604 0.83 AXL (0.64) METAXLMST1RAURKAJAK2
SCHEMBL16089972 0.81 MET (1.00) METAXL
Trifluoroacetic Acid SCHEMBL166874 0.81 MET (0.68) METAXLAURKAABL1LCK
Trifluoroacetic Acid SCHEMBL695728 0.80 MET (0.61) METAXLMST1RAURKAJAK2
Trifluoroacetic Acid SCHEMBL698912 0.80 MET (0.59) METAXLMST1RAURKAJAK2
SCHEMBL30716505 0.79 MET (0.70) METAXLMST1RAURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2014-11-26 EP disclosed
EP-2423208-A1 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH (DE) 2012-02-29 EP disclosed